ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2011

Jul 6, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2011-07-01

Reporting Person: Clendeninn Neil James (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-07-01	Common Stock	M	3347	$3.889	Acquired	3347	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-07-01	Stock Options	$3.889	M	2395	Disposed	2011-09-16	Common (2395)	Direct
2011-07-01	Stock Options	$3.889	M	952	Disposed	2011-12-20	Common (952)	Direct